Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer

Journal of Contemporary Brachytherapy

Volumn 4, Issue 4, 2012, Pages 247-252

  Kellas Ślȩczka, Sylwia ^a   Wojcieszek, Piotr ^a   Białas, Brygida ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Brachytherapy; Endometrial cancer; HDR; LDR; Vaginal cylinder; Vaginal vault

Indexed keywords

ADJUVANT VAGINAL BRACHYTHERAPY; ADL DISABILITY; BLOOD TOXICITY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DIARRHEA; DISEASE FREE SURVIVAL; EARLY CANCER; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FECES INCONTINENCE; GASTROINTESTINAL TOXICITY; HUMAN; LYMPH NODE DISSECTION; MENORRHAGIA; METRORRHAGIA; OVERALL SURVIVAL; PARTIAL BODY RADIATION; POSTMENOPAUSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; REVIEW; SKIN TOXICITY; URINARY URGENCY; URINE INCONTINENCE;

EID: 84874991696     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2012.32560     Document Type: Review

References (33)

1. Amant F, Mirza MR, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet 2012; 119 Suppl 2: S110-117.
2. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983; 15: 10-17.
3. Evans T, Sany O, Pearmain P et al. Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. Br J Cancer 2011; 104: 1505-1510.
4. Gottwald L, Pluta P, Piekarski J et al. Long-term survival of endometrial cancer patients. Arch Med Sci 2010; 6: 937-944.
5. Press JZ, Gotlieb WH. Controversies in the treatment of early stage endometrial carcinoma. Obstet Gynecol Int 2012; 5: 784-790.
6. Kitchener H, Swart AM, Qian Q et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 2009; 373: 125-136.
7. Benedetti Panici P, Basile S, Maneschi F et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100: 1707-1716.
8. Todo Y, Kato H, Kaneuchi M et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010; 375: 1165-1172.
9. Ugaki H, Kimura T, Miyatake T et al. Intraoperative frozen section assessment of myometrial invasion and histology of endometrial cancer using the revised FIGO staging system. Int J Gynecol Cancer 2011; 21: 1180-1184.
10. Cade TJ, Quinn MA, McNally OM et al. Predictive value of magnetic resonance imaging in assessing myometrial invasion in endometrial cancer: is radiological staging sufficient for planning conservative treatment? Int J Gynecol Cancer 2010; 20: 1166-1169.
11. How J, Lau S, Press J et al. Accuracy of sentinel lymph node de tection following intra-operative cervical injection for endometrial cancer: A prospective study. Gynecol Oncol 2012; 127: 332-337.
12. Sharma C, Deutsch I, Lewin SN et al. Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer. Am J Obstet Gynecol 2011; 205: 562 e1-9.
13. Poulsen HK, Jacobsen M, Bertelsen K et al. Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group. Ugeskr Laeger 1997; 159: 3403-3407.
14. Aalders J, Abeler V, Kolstad P et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980; 56: 419-427.
15. Nout RA, van de Poll-Franse LV, Lybeert ML et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. J Clin Oncol 2011; 29: 1692-1700.
16. Creutzberg CL, van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000; 355: 1404-1411.
17. Keys HM, Roberts JA, Brunetto VL et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92: 744-751.
18. Blake P, Swart AM, Orton J et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomized trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009; 373: 137-146.
19. Donnelly ED, Rakhra S, Helenowski I et al. Dosimetry and toxicity outcomes in postoperative high-dose-rate intracavitary brachytherapy for endometrial carcinoma. J Contemp Brachyther 2012; 4: 135-140.
20. Eltabbakh GH, Piver MS, Hempling RE et al. Excellent longterm survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys 1997; 38: 373-380.
21. Weiss E, Hirnle P, Arnold-Bofinger H et al. Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy. Gynecol Oncol 1998; 71: 72-76.
22. Chadha M, Nanavati PJ, Liu P et al. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 1999; 75: 103-107.
23. Anderson JM, Stea B, Hallum AV et al. High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys 2000; 46: 417-425.
24. Rittenberg PV, Lotocki RJ, Heywood MS et al. Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors. Gynecol Oncol 2005; 98: 434-438.
25. Jolly S, Vargas C, Kumar T et al. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol 2005; 97: 887-892.
26. Alektiar KM, Venkatraman E, Chi DS et al. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 2005; 62: 111-117.
27. Lin LL, Mutch DG, Rader JS et al. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 2007; 106: 215-220.
28. McCloskey SA, Tchabo NE, Malhotra HK et al. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecol Oncol 2010; 116: 404-407.
29. Nout RA, Putter H, Jürgenliemk-Schulz IM et al. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. Eur J Cancer 2012; 48: 1638-1648.
30. Nout RA, Smit VT, Putter H et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomized trial. Lancet 2010; 375: 816-823.
31. Hogberg T, Signorelli M, de Oliveira CF et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancerresults from two randomized studies. Eur J Cancer 2010; 46: 2422-2431.
32. Maggi R, Lissoni A, Spina F et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomized trial. Br J Cancer 2006; 95: 266-271.
33. Susumu N, Sagae S, Udagawa Y et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008; 108: 226-233.